Annual ROE
0.15%
-6.98%-97.90%
31 December 2023
Summary:
Supernus Pharmaceuticals annual return on equity is currently 0.15%, with the most recent change of -6.98% (-97.90%) on 31 December 2023. During the last 3 years, it has fallen by -18.79% (-99.21%). SUPN annual ROE is now -99.97% below its all-time high of 569.89%, reached on 31 December 2011.SUPN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
6.32%
+5.76%+1028.57%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly return on equity is currently 6.32%, with the most recent change of +5.76% (+1028.57%) on 30 September 2024. Over the past year, it has increased by +3.46% (+120.98%). SUPN quarterly ROE is now -97.68% below its all-time high of 272.11%, reached on 30 September 2012.SUPN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.9% | +121.0% |
| 3 y3 years | -99.2% | -41.1% |
| 5 y5 years | -99.5% | -70.9% |
SUPN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -99.2% | at low | -41.1% | +474.0% |
| 5 y | 5 years | -99.5% | at low | -70.9% | +474.0% |
| alltime | all time | -100.0% | +100.1% | -97.7% | +100.7% |
Supernus Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 6.32%(+1028.6%) |
| June 2024 | - | 0.56%(-133.1%) |
| Mar 2024 | - | -1.69%(-1307.1%) |
| Dec 2023 | 0.15%(-97.9%) | 0.14%(-95.1%) |
| Sept 2023 | - | 2.86%(-41.8%) |
| June 2023 | - | 4.91%(-18.4%) |
| Mar 2023 | - | 6.02%(-16.3%) |
| Dec 2022 | 7.13%(+4.1%) | 7.19%(+58.4%) |
| Sept 2022 | - | 4.54%(-35.5%) |
| June 2022 | - | 7.04%(-23.3%) |
| Mar 2022 | - | 9.18%(+34.4%) |
| Dec 2021 | 6.85%(-63.8%) | 6.83%(-36.4%) |
| Sept 2021 | - | 10.74%(-21.5%) |
| June 2021 | - | 13.69%(-14.1%) |
| Mar 2021 | - | 15.93%(-16.5%) |
| Dec 2020 | 18.94%(-12.2%) | 19.07%(-7.3%) |
| Sept 2020 | - | 20.58%(+2.9%) |
| June 2020 | - | 20.00%(-4.7%) |
| Mar 2020 | - | 20.99%(-3.1%) |
| Dec 2019 | 21.57%(-30.0%) | 21.67%(-0.3%) |
| Sept 2019 | - | 21.73%(-6.1%) |
| June 2019 | - | 23.14%(-5.7%) |
| Mar 2019 | - | 24.55%(-16.6%) |
| Dec 2018 | 30.81%(+23.5%) | 29.44%(+0.4%) |
| Sept 2018 | - | 29.33%(+0.9%) |
| June 2018 | - | 29.08%(+3.6%) |
| Mar 2018 | - | 28.07%(+12.3%) |
| Dec 2017 | 24.95% | 24.99%(-9.2%) |
| Sept 2017 | - | 27.53%(-50.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | 55.12%(-4.2%) |
| Mar 2017 | - | 57.53%(-8.9%) |
| Dec 2016 | 65.21%(+200.9%) | 63.15%(-3.5%) |
| Sept 2016 | - | 65.44%(+188.2%) |
| June 2016 | - | 22.71%(+31.7%) |
| Mar 2016 | - | 17.25%(+7.7%) |
| Dec 2015 | 21.67%(-173.6%) | 16.02%(+21.7%) |
| Sept 2015 | - | 13.16%(+93.2%) |
| June 2015 | - | 6.81%(-32.9%) |
| Mar 2015 | - | 10.15%(-137.7%) |
| Dec 2014 | -29.46%(-85.5%) | -26.95%(-74.7%) |
| Sept 2014 | - | -106.41%(-47.9%) |
| June 2014 | - | -204.05%(-30.6%) |
| Mar 2014 | - | -293.90%(+15.1%) |
| Dec 2013 | -202.72%(+46.8%) | -255.39%(+5.3%) |
| Sept 2013 | - | -242.64%(+31.6%) |
| June 2013 | - | -184.36%(+7.6%) |
| Mar 2013 | - | -171.34%(-3.8%) |
| Dec 2012 | -138.13%(-124.2%) | -178.16%(-165.5%) |
| Sept 2012 | - | 272.11%(-131.9%) |
| June 2012 | - | -853.15%(+221.3%) |
| Mar 2012 | - | -265.52%(+55.6%) |
| Dec 2011 | 569.89%(+556.7%) | -170.62%(-371.3%) |
| Sept 2011 | - | 62.88%(-6.6%) |
| June 2011 | - | 67.30%(+37.6%) |
| Mar 2011 | - | 48.91%(+128.9%) |
| Dec 2010 | 86.78%(-1261.7%) | 21.37%(-45.1%) |
| Sept 2010 | - | 38.93%(-70.7%) |
| Dec 2009 | -7.47%(-101.5%) | 133.02% |
| Dec 2008 | 496.23% | - |
FAQ
- What is Supernus Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual ROE year-on-year change?
- What is Supernus Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly ROE year-on-year change?
What is Supernus Pharmaceuticals annual return on equity?
The current annual ROE of SUPN is 0.15%
What is the all time high annual ROE for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual return on equity is 569.89%
What is Supernus Pharmaceuticals annual ROE year-on-year change?
Over the past year, SUPN annual return on equity has changed by -6.98% (-97.90%)
What is Supernus Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SUPN is 6.32%
What is the all time high quarterly ROE for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly return on equity is 272.11%
What is Supernus Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SUPN quarterly return on equity has changed by +3.46% (+120.98%)